CalAmp (id:8364 CAMP)
5.41 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 7:49:53 PM)
Exchange closed, opens in 13 hours 40 minutes
-3.57 USD (-3.57%)
-34.58 USD (-34.58%)
-47.83 USD (-47.83%)
46.22 USD (46.22%)
-36.43 USD (-36.43%)
-97.72 USD (-97.72%)
-98.74 USD (-98.74%)
-44.57 USD (-44.57%)
About CalAmp
Market Capitalization 105.52M
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001 for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP to treat synaptic Ras GTPase activating protein 1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
| Headquarters (address) |
One Kendall Square Building 1400 West Cambridge 02139 MA United States |
| Phone | 617 651 8867 |
| Website | https://www.camp4tx.com |
| Employees | 58 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | CAMP |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 0.020 - 12.30 |
| Market Capitalization | 105.52M |
| P/E trailing | -15.03 |
| P/E forward | -1.80 |
| Price/Sale | 301.49 |
| Price/Book | -0.060 |
| EPS | -2.55 |
| EPS United States (ID:6, base:3402) | 24.22 |